Works matching AU Fukuoka, Masahiro


Results: 112
    1
    2
    3
    4

    Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, which was administered to patients with advanced solid tumors on days 1 and 8 in 3-week courses.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 285, doi. 10.1007/s00280-006-0382-7
    By:
    • Tamura, Kenji;
    • Nakagawa, Kazuhiko;
    • Kurata, Takayasu;
    • Satoh, Taroh;
    • Nogami, Toshiji;
    • Takeda, Koji;
    • Mitsuoka, Shigeki;
    • Yoshimura, Naruo;
    • Kudoh, Shinzoh;
    • Negoro, Shunichi;
    • Fukuoka, Masahiro
    Publication type:
    Article
    5
    6
    7
    8
    9
    10

    Public assistance and survival equality in patients with EGFR mutation-positive lung cancer.

    Published in:
    Japanese Journal of Clinical Oncology, 2025, v. 55, n. 3, p. 228, doi. 10.1093/jjco/hyae167
    By:
    • Uryu, Kiyoaki;
    • Imamura, Yoshinori;
    • Shimoyama, Rai;
    • Mase, Takahiro;
    • Fujimura, Yoshiaki;
    • Hayashi, Maki;
    • Ohtaki, Megu;
    • Otani, Keiko;
    • Hibino, Makoto;
    • Horiuchi, Shigeto;
    • Fukui, Tomoya;
    • Fukai, Ryuta;
    • Chihara, Yusuke;
    • Iwase, Akihiko;
    • Yamada, Noriko;
    • Tamura, Yukihiro;
    • Harada, Hiromasa;
    • Tsuya, Asuka;
    • Okabe, Takafumi;
    • Fukuoka, Masahiro
    Publication type:
    Article
    11

    Stepwise prolongation of overall survival from first to third generation EGFR-TKIs for EGFR mutation-positive non-small-cell lung cancer: the Tokushukai REAl-world Data project (TREAD 01).

    Published in:
    Japanese Journal of Clinical Oncology, 2024, v. 54, n. 3, p. 319, doi. 10.1093/jjco/hyad162
    By:
    • Uryu, Kiyoaki;
    • Imamura, Yoshinori;
    • Shimoyama, Rai;
    • Mase, Takahiro;
    • Fujimura, Yoshiaki;
    • Hayashi, Maki;
    • Ohtaki, Megu;
    • Otani, Keiko;
    • Hibino, Makoto;
    • Horiuchi, Shigeto;
    • Fukui, Tomoya;
    • Fukai, Ryuta;
    • Chihara, Yusuke;
    • Iwase, Akihiko;
    • Yamada, Noriko;
    • Tamura, Yukihiro;
    • Harada, Hiromasa;
    • Shinozaki, Nobuaki;
    • Tsuya, Asuka;
    • Fukuoka, Masahiro
    Publication type:
    Article
    12
    13

    Early Palliative Intervention for Patients with Advanced Cancer.

    Published in:
    Japanese Journal of Clinical Oncology, 2013, v. 43, n. 8, p. 788, doi. 10.1093/jjco/hyt074
    By:
    • Otsuka, Masatomo;
    • Koyama, Atsuko;
    • Matsuoka, Hiromichi;
    • Niki, Minoru;
    • Makimura, Chihiro;
    • Sakamoto, Ryo;
    • Sakai, Kiyohiro;
    • Fukuoka, Masahiro
    Publication type:
    Article
    14
    15

    A Phase II Study of Cisplatin and Irinotecan As Induction Chemotherapy Followed by Concomitant Thoracic Radiotherapy with Weekly Low-dose Irinotecan in Unresectable, Stage III, Non-Small Cell Lung Cancer: JCOG 9706.

    Published in:
    Japanese Journal of Clinical Oncology, 2011, v. 41, n. 1, p. 25, doi. 10.1093/jjco/hyq163
    By:
    • Takeda, Koji;
    • Negoro, Shunichi;
    • Tanaka, Masahiro;
    • Fukuda, Haruhiko;
    • Nakagawa, Kazuhiko;
    • Kawahara, Masaaki;
    • Semba, Hiroshi;
    • Kudoh, Shinzoh;
    • Sawa, Toshiyuki;
    • Saijo, Nagahiro;
    • Fukuoka, Masahiro
    Publication type:
    Article
    16
    17

    Lung Cancer Working Group Report.

    Published in:
    Japanese Journal of Clinical Oncology, 2010, v. 40, n. suppl_1, p. i7, doi. 10.1093/jjco/hyq121
    By:
    • Saijo, Nagahiro;
    • Fukuoka, Masahiro;
    • Thongprasert, Sumitra;
    • Ichinose, Yukito;
    • Mitsudomi, Tetsuya;
    • Mok, Tony Shu Kam;
    • Ohe, Yuichiro;
    • Park, Keunchil;
    • Wu, Yi-Long
    Publication type:
    Article
    18
    19
    20
    21
    22

    A Phase I/II Study Comparing Regimen Schedules of Gemcitabine and Docetaxel in Japanese Patients with Stage IIIB/IV Non-small Cell Lung Cancer.

    Published in:
    Japanese Journal of Clinical Oncology, 2005, v. 35, n. 4, p. 181, doi. 10.1093/jjco/hyi057
    By:
    • Matsui, Kaoru;
    • Hirashima, Tomonori;
    • Nitta, Takashi;
    • Kobayashi, Masashi;
    • Ogata, Yoshitaka;
    • Furukawa, Mitsugi;
    • Kudoh, Shinzoh;
    • Yoshimura, Naruo;
    • Mukohara, Toru;
    • Yamauchi, Setsuko;
    • Shiraishi, Satoshi;
    • Kamoi, Hiroshi;
    • Negoro, Syunichi;
    • Takeda, Kouji;
    • Nakagawa, Kazuhiko;
    • Takada, Minoru;
    • Yana, Takashi;
    • Fukuoka, Masahiro
    Publication type:
    Article
    23
    24
    25
    26
    27

    A phase I study of S-1 with concurrent radiotherapy in elderly patients with locally advanced non-small cell lung cancer.

    Published in:
    Investigational New Drugs, 2013, v. 31, n. 3, p. 599, doi. 10.1007/s10637-012-9833-7
    By:
    • Hasegawa, Yoshikazu;
    • Okamoto, Isamu;
    • Takezawa, Ken;
    • Miyazaki, Masaaki;
    • Tsurutani, Junji;
    • Yonesaka, Kimio;
    • Morinaga, Ryotaroh;
    • Tsuya, Asuka;
    • Terashima, Masaaki;
    • Kudoh, Toshihiro;
    • Azuma, Koichi;
    • Kurata, Takayasu;
    • Nishikawa, Tatsuyuki;
    • Fukuoka, Masahiro;
    • Nishimura, Yasumasa;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    28
    29
    30

    Phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group (WJTOG) study.

    Published in:
    Investigational New Drugs, 2007, v. 25, n. 4, p. 377, doi. 10.1007/s10637-007-9039-6
    By:
    • Koji Takeda;
    • Nobuhide Takifuji;
    • Shunichi Negoro;
    • Kiyoyuki Furuse;
    • Shinichiro Nakamura;
    • Yoshiki Takada;
    • Takanobu Hoso;
    • Shinichi Hayasaka;
    • Takashi Nakano;
    • Jun Araki;
    • Hiroshi Senba;
    • Fumiyuki Iwami;
    • Yasufumi Yamaji;
    • Masahiro Fukuoka;
    • Harumichi Ikegami
    Publication type:
    Article
    31
    32
    33
    34
    35

    Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB–IIIA non-small cell lung cancer (WJTOG0101).

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 12, p. 2216, doi. 10.1007/s10147-021-02012-9
    By:
    • Yamaguchi, Masafumi;
    • Tada, Hirohito;
    • Mitsudomi, Tetsuya;
    • Seto, Takashi;
    • Yokoi, Kohei;
    • Katakami, Nobuyuki;
    • Nakagawa, Kazuhiko;
    • Oda, Makoto;
    • Ohta, Mitsunori;
    • Sawa, Toshiyuki;
    • Yamashita, Motohiro;
    • Iked, Norihiko;
    • Saka, Hideo;
    • Higashiyama, Masahiko;
    • Nomori, Hiroaki;
    • Semba, Hiroshi;
    • Negoro, Shunichi;
    • Chiba, Yasutaka;
    • Shimokawa, Mototsugu;
    • Fukuoka, Masahiro
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43

    Dose escalation study of carboplatin with fixed-dose etoposide plus granulocyte-colony stimulating factor in patients with small cell lung carcinoma: A study of the lung cancer study group of west Japan.

    Published in:
    Cancer (0008543X), 1996, v. 77, n. 1, p. 63, doi. 10.1002/(SICI)1097-0142(19960101)77:1<63::AID-CNCR12>3.0.CO;2-6
    By:
    • Katakami, Nobuyuki;
    • Takada, Minoru;
    • Negoro, Shunichi;
    • Ota, Katsuyasu;
    • Fujita, Jiro;
    • Furuse, Kiyoyuki;
    • Ariyoshi, Yutaka;
    • Ikegami, Harumichi;
    • Fukuoka, Masahiro
    Publication type:
    Article
    44
    45
    46
    47
    48
    49

    Catheter detachment.

    Published in:
    Oxford Medical Case Reports, 2015, v. 2015, n. 5, p. 292, doi. 10.1093/omcr/omv038
    By:
    • Takayo Ota;
    • Hiroshi Tsukuda;
    • Masahiro Tokunaga;
    • Norifumi Nishida;
    • Yoshikazu Hasegawa;
    • Tomohiro Suzumura;
    • Masahiro Fukuoka
    Publication type:
    Article
    50